| 2D Structure | |
| CID | 5273568 |
| IUPAC Name | 7-hydroxy-6-methoxy-8-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-2-one |
| InChI | InChI=1S/C16H18O10/c1-23-7-4-6-2-3-9(18)25-14(6)15(11(7)20)26-16-13(22)12(21)10(19)8(5-17)24-16/h2-4,8,10,12-13,16-17,19-22H,5H2,1H3/t8-,10-,12+,13-,16+/m1/s1 |
| InChI Key | CRSFLLTWRCYNNX-QBNNUVSCSA-N |
| Canonical SMILES | None |
| Isomeric SMILES | None |
| Molecular Formula | C16H18O10 |
| Molecular Weight | 370.31 |
| synonyms | ['Fraxin', '524-30-1', 'Fraxetin-8-O-glucoside', 'V7M270Y072', '2H-1-Benzopyran-2-one, 8-(beta-D-glucopyranosyloxy)-7-hydroxy-6-methoxy-', 'CHEBI:5170', 'DTXSID30200410', 'RefChem:600391', '7,8-dihydroxy-6-methoxycoumarin-8-beta-D-glucoside', 'DTXCID30122901', '2H-1-Benzopyran-2-one,8-(beta-D-glucopyranosyloxy)-7-hydroxy-6-methoxy-', '208-355-5', '7-hydroxy-6-methoxy-8-((2S,4R,5S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl)oxychromen-2-one', 'Fraxoside', 'FRAXINE', 'MFCD00010093', '8-(beta-D-Glucopyranosyloxy)-7-hydroxy-6-methoxy-2H-1-benzopyran-2-one', '7-Hydroxy-6-methoxy-8-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-2H-chromen-2-one', '7-hydroxy-6-methoxy-8-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-2-one', '7-hydroxy-6-methoxy-8-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-chromen-2-one', '2H-1-Benzopyran-2-one, 8-(.beta.-D-glucopyranosyloxy)-7-hydroxy-6-methoxy-', 'UNII-V7M270Y072', 'Fraxin (Standard)', 'EINECS 208-355-5', 'Fraxetin-8-glucoside', 'FRAXIN [MI]', 'Fraxin, analytical standard', 'FRAXETOL 8-GLUCOSIDE', 'MLS002473090', 'fraxetin-8-O-beta-D-glucoside', 'CHEMBL293864', 'MEGxp0_000484', 'orb1303753', 'SCHEMBL1227439', 'ACon1_000325', 'EX-A8002Y', 'HY-N0579R', 'WLZ4730', 'CRSFLLTWRCYNNX-QBNNUVSCSA-N', 'fraxetin-8-beta-D-glucopyranoside', 'HMS2225L24', 'HY-N0579', 'fraxetin-8-O-beta-D-glucopyranoside', 'BDBM50428429', 's9296', 'AKOS037514646', 'CCG-268292', 'EBC-615938', 'FF73926', 'NCGC00169184-01', '7-hydroxy-6-methoxy-8-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2H-chromen-2-one', 'AC-34583', 'AS-77295', 'SMR001397192', 'FRAXETIN 8-.BETA.-D-GLUCOPYRANOSIDE', 'CS-0009114', 'NS00032506', 'Q1452081', 'BRD-K31984062-001-01-6', '7,8-Dihydroxy-6-methoxycoumarin 8-|A-D-glucopyranoside', '8-(beta-d-glucopyranosyloxy)-7-hydroxy-6-methoxycoumarin', '7,8-Dihydroxy-6-methoxycoumarin 8-beta-D-glucopyranoside', '7,8-Dihydroxy-6-methoxycoumarin-beta-D-glucopyranoside hplc', '7,8-DIHYDROXY-6-METHOXYCOUMARIN 8-.BETA.-D-GLUCOPYRANOSIDE', '7-hydroxy-6-methoxy-2-oxo-2H-chromen-8-yl beta-D-glucopyranoside', '7-Hydroxy-6-methoxy-2-oxo-2H-1-benzopyran-8-yl beta-D-glucopyranoside', 'InChI=1/C16H18O10/c1-23-7-4-6-2-3-9(18)25-14(6)15(11(7)20)26-16-13(22)12(21)10(19)8(5-17)24-16/h2-4,8,10,12-13,16-17,19-22H,5H2,1H3/t8-,10-,12+,13-,16+/m1/s'] |
From Pubchem